News
Omniscopiq appoints alphaXRT as exclusive distributor for Australia & New Zealand
4th February 2025
We’re thrilled to announce alpha XRT as our exclusive distributor for Australia and New Zealand!
This partnership marks another important milestone for Omniscopiq as we continue to expand our reach and bring cutting-edge innovative technologies to customers in Australia and New Zealand.
alphaXRT was founded in 1990 and is the leading independent supplier of radiation oncology solutions in Australasia. We are excited to work together with alphaXRT in their vision of giving local clinicians access to the world’s most innovative solutions.
Omniscopiq appoints Xiel Ltd as exclusive distributor for the United Kingdom and Ireland
11th February 2025
We’re thrilled to announce Xiel Ltd as our exclusive distributor for the United Kingdom & Ireland!
This partnership marks another important milestone for Omniscopiq as we continue to expand our reach and bring cutting-edge innovative technologies to customers in the UK and Ireland
Xiel is a specialist distributor of medical technologies in the UK and Ireland. They work with global leading solution providers; therefore, continuously improving efficiency and quality for their customers
Announcing the formation of our clinical advisory board
10th February 2025
We’re delighted to announce the formation of our Clinical Advisory Board
We are privileged to have appointed a clinical advisory board consisting of experienced professionals in the field of radiation therapy. Our clinical advisory board members define user needs and help us to ensure that the tools that we develop deliver real benefits to patients and the dedicated staff who treat them
For more information, please go to clinical advisory board
Omniscopiq appoints CEO
1st July 2024
Omniscopiq has appointed James Turner as CEO.
James brings over 28 years of radiation therapy experience to the company. Graduating from the University of the West of England in 1996, with a degree in radiotherapy, James practiced clinically for 7 years before joining industry. He subsequently worked for two start-ups, in product management and commercial roles, before joining Varian Medical Systems in 2018 where he managed their Surface Guidance business across EMEA.
Verkstadsgatan 8,
753 23 Uppsala,
Sweden
+46 18 495 12 34
© 2024 Omniscopiq All Rights Reserved.
Omniscopiq appoints Axion XRT as exclusive distributor for the Americas
14th January 2025
We’re thrilled to announce Axion XRT as our exclusive distributor for the Americas!
This partnership marks a major milestone for Omniscopiq as we continue to expand our reach and bring cutting-edge innovative technologies to customers across North and South America.
With Axion XRT's expertise, and over 100 years of combined experience in sales, service, and support within the field of radiation therapy, we’re ready to deliver our transformative solutions across the region.
Omniscopiq appoints Tecnologie Avanzate as exclusive distributor for Italy
21st January 2025
We’re thrilled to announce Tecnologie Avanzate as our exclusive distributor for Italy!
This partnership marks another important milestone for Omniscopiq as we continue to expand our reach and bring cutting-edge innovative technologies to customers in Italy
Since 1974 Tecnologie Avanzate has been growing in the Italian Market by introducing innovative medical technologies in the field of Nuclear Physics applied to Radiology, Nuclear Medicine and Radiotherapy and we’re excited to be working with them.
Omniscopiq appoints MEDITEST as exclusive distributor for France & Maghreb
24th January 2025
We’re thrilled to announce MEDITEST as our exclusive distributor for France & Maghreb!
This partnership marks another important milestone for Omniscopiq as we continue to expand our reach and bring cutting-edge innovative technologies to customers in France & Maghreb
Founded in 1984, MEDITEST specializes in providing quality control equipment for medical imaging facilities, nuclear medicine, radiotherapy, and research centres. As a pioneer in quality control for medical imaging and with 40 years of experience, MEDITEST stands at the forefront of innovation, meeting the increasingly stringent regulatory standards in this field
Omniscopiq appoints DTA as exclusive distributor for Spain & Portugal
28th January 2025
We’re thrilled to announce Distribución de Tecnologías Avanzadas S.L. (DTA) as our exclusive distributor for Spain and Portugal!
This partnership marks another important milestone for Omniscopiq as we continue to expand our reach and bring cutting-edge innovative technologies to customers in Spain and Portugal
DTA is a team with international experience with the mission of providing their clients with the most innovative solutions, which allow them to improve the quality of life-saving treatments in the fields of radiotherapy and diagnostic imaging.